Side effects of commonly prescribed analgesic medications

Physical Medicine and Rehabilitation Clinics of North America

Volumn 25, Issue 2, 2014, Pages 457-470

  Carter, Gregory T ^a,b   Duong, Vicky ^c   Ho, Stanley ^c   Ngo, Kathryn C ^c   Greer, Christopher L ^a,c   Weeks, Douglas L ^a,c  

^a St Luke's Rehabilitation Institute   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Adverse drug events; Analgesics; Chronic pain; Patient counseling; Side effects

Indexed keywords

ALFENTANIL; ANALGESIC AGENT; BUPRENORPHINE; BUTORPHANOL; CAPSAICIN; CARBAMAZEPINE; CODEINE; CYCLOOXYGENASE 2 INHIBITOR; FENTANYL; HYDROCODONE; HYDROMORPHONE; INDOMETACIN; KETOROLAC; LAMOTRIGINE; LEVORPHANOL; LIDOCAINE; METHADONE; MORPHINE; OXCARBAZEPINE; OXYCODONE; OXYMORPHONE; PARACETAMOL; PETHIDINE; PHENYTOIN; PRILOCAINE; SALICYLIC ACID METHYL ESTER; SUFENTANIL; TAPENTADOL; TRAMADOL; UNINDEXED DRUG; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ABDOMINAL CRAMP; ABDOMINAL PAIN; ABNORMAL RESPIRATORY SOUND; ABNORMAL VISION; ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS; AGITATION; ALTERED MENTAL STATUS; ANALGESIA; ANALGESIC NEPHROPATHY; ANEMIA; ANOREXIA; ANXIETY DISORDER; APNEA; APPLICATION SITE ERYTHEMA; APPLICATION SITE IRRITATION; APPLICATION SITE PRURITUS; APPLICATION SITE RASH; APPLICATION SITE REACTION; ASTHENIA; ATAXIA; ATELECTASIS; BALANCE IMPAIRMENT; BLADDER SPASM; BLURRED VISION; BRADYCARDIA; BRONCHITIS; BURN; BURNING SENSATION; CHEST TIGHTNESS; COGNITIVE DEFECT; COMA; CONFUSION; CONSTIPATION; COORDINATION DISORDER; DEATH; DELIRIUM; DEPRESSION; DERMATITIS; DIAPHORESIS; DIARRHEA; DIPLOPIA; DISORIENTATION; DIZZINESS; DROWSINESS; DRY SKIN; DYSMENORRHEA; DYSPEPSIA; DYSPNEA; EDEMA; ERYTHEMA; EUPHORIA; FATIGUE; FEAR; FEVER; FLATULENCE; FLU LIKE SYNDROME; FLUSHING; FOLLOW UP; GAIT DISORDER; GINGIVA HYPERPLASIA; HALLUCINATION; HEADACHE; HEART ARREST; HEART ARRHYTHMIA; HEART PALPITATION; HUMAN; HYPERTENSION; HYPERTHERMIA; HYPERVOLEMIA; HYPOALBUMINEMIA; HYPOKALEMIA; HYPOMAGNESEMIA; HYPOPHOSPHATEMIA; HYPOTENSION; HYPOXIA; INDIGESTION; INFUSION SITE PAIN; INSOMNIA; INTESTINE OBSTRUCTION; KIDNEY DYSFUNCTION; LETHARGY; LEUKOPENIA; LIVER DYSFUNCTION; LOSS OF APPETITE; LUNG EDEMA; MEASLES LIKE RASH; MENTAL HEALTH; METHEMOGLOBINEMIA; MOOD DISORDER; MOOD SWING; MUSCLE RIGIDITY; MUSCLE SPASM; MUSCLE TWITCH; MYOCLONUS; NAUSEA; NEPHROTOXICITY; NERVOUSNESS; NEUTROPENIA; NOSE OBSTRUCTION; NYSTAGMUS; OLIGURIA; PAIN; PALLOR; PANCYTOPENIA; PAPULE; PARALYTIC ILEUS; PARESTHESIA; PATIENT MONITORING; PERIORBITAL EDEMA; PERIPHERAL EDEMA; PETECHIA; PHARYNGITIS; PHARYNX DISEASE; PLEURA EFFUSION; PRESCRIPTION; PRIORITY JOURNAL; PRURITUS; QT PROLONGATION; RASH; RESPIRATION DEPRESSION; RESPIRATORY DISTRESS; RESTLESSNESS; REVIEW; RHINITIS; RHINOPHARYNGITIS; SEDATION; SEIZURE; SEX DIFFERENCE; SHOCK; SINUSITIS; SKIN BRUISING; SKIN EDEMA; SKIN IRRITATION; SKIN REDNESS; SKIN SWELLING; SLURRED SPEECH; SOMNOLENCE; STEVENS JOHNSON SYNDROME; STRIDOR; SWEATING; TACHYCARDIA; TOXIC EPIDERMAL NECROLYSIS; TREMOR; TRISMUS; UPPER RESPIRATORY TRACT INFECTION; URETHRAL SPASM; URINE RETENTION; URTICARIA; VATER PAPILLA STENOSIS; VERTIGO; VISUAL DISORDER; VOMITING; WEAKNESS; WHEEZING; XEROSTOMIA; CHRONIC PAIN; COUNSELING; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; INCIDENCE; MALE; PAIN, INTRACTABLE; PATHOPHYSIOLOGY; PHYSIOLOGIC MONITORING; PROCEDURES; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX;

ANALGESICS; ANALGESICS, OPIOID; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHRONIC PAIN; COUNSELING; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HUMANS; INCIDENCE; MALE; MONITORING, PHYSIOLOGIC; PAIN MANAGEMENT; PAIN, INTRACTABLE; PROGNOSIS; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX;

EID: 84899660303     PISSN: 10479651     EISSN: 15581381     Source Type: Journal    
DOI: 10.1016/j.pmr.2014.01.007     Document Type: Review

References (10)

1. Jensen M.P., Abresch R.T., Carter G.T., et al. Chronic pain in persons with neuromuscular disorders. Arch Phys Med Rehabil 2005, 86(6):1155-1163.
2. Molton I., Jensen M.P., Ehde D.M., et al. Coping with chronic pain among younger, middle-aged, and older adults living with neurologic injury and disease: a role for experiential wisdom. J Aging Health 2008, 20:972-996.
3. Fu H., Price K.L., Nilsson M.E., et al. Identifying potential adverse events dose-response relationships via bayesian indirect and mixed treatment comparison models. J Biopharm Stat 2013, 23(1):26-42.
4. Schnipper J.L., Kirwin J.L., Cotugno M.C., et al. Role of pharmacist counseling in preventing adverse drug events after hospitalization. Arch Intern Med 2006, 166(5):565-571.
5. Altavela J.L., Jones M.K., Ritter M. A prospective trial of a clinical pharmacy intervention in a primary care practice in a capitated payment system. J Manag Care Pharm 2008, 14(9):831-843.
6. Ross S., Ryan C., Duncan E.M., et al. Perceived causes of prescribing errors by junior doctors in hospital inpatients: a study from the PROTECT programme. BMJ Qual Saf 2013, 22(2):97-102.
7. Kalthoff S., Winkler A., Freiberg N., et al. Gender matters: Estrogen receptor alpha (ERα) and histone deacetylase (HDAC) 1 and 2 control the gender-specific transcriptional regulation of human uridine diphosphate glucuronosyltransferases genes (UGT1A). J Hepatol 2013, 59(4):797-804.
8. Wiesenfeld-Hallin Z. Sex differences in pain perception. Gend Med 2005, 2(3):137-145.
9. Wielage R., Bansal M., Wilson K., et al. Cost-effectiveness of duloxetine in chronic low back pain: a Quebec societal perspective. Spine 2013, 38(11):936-946.
10. Smith M.T., Moore B.J. Pregabalin for the treatment of fibromyalgia. Expert Opin Pharmacother 2012, 13(10):1527-1533.